Ping An Biomedical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PASW research report →
Price Chart
About the company
Ping An Biomedical Co. , Ltd. delivers comprehensive supply chain management services tailored for the clothing sector.
- CEO
- Pijun Liu
- IPO
- 2025
- Employees
- 7
- HQ
- Hong Kong, HK
Get TickerSpark's AI analysis on PASW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.19M
- P/E
- -0.52
- PEG
- 0.01
- P/S
- 0.83
- P/B
- 0.12
- EV/EBITDA
- -2.34
- Div Yield
- 0.00%
- Gross Margin
- 9.27%
- Op Margin
- -41.34%
- Net Margin
- -14.78%
- ROE
- -6.11%
- ROIC
- -11.92%
Latest fiscal year · YoY change
- Revenue
- $34.15M-61.0%
- Gross Profit
- $949.50K-82.5%
- Op Income
- $-14,701,470
- Net Income
- $-12,829,206-899.0%
- EPS
- $-27.60-867.7%
- OCF Growth
- -143.9%
- FCF Growth
- -143.9%
- 52W High
- $28.56
- 52W Low
- $1.07
- 50D MA
- $4.09
- 200D MA
- $5.64
- Beta
- 2.27
- RSI (14)
- 29
- Avg Volume
- 188.54K
No earnings-call transcripts are available for PASW yet.
- Free Float
- 66.1%
- Shares Outstanding
- 2.82M
- Float Shares
- 1.87M
of shares held by institutions
3 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 14, 25 | Liu Pijun (PJL) | other | 0 |
| Oct 14, 25 | Liu Xianzhi (XZL) | other | 0 |
| Oct 14, 25 | Yang Hongli (HLY) | other | 0 |
| Jul 29, 25 | Liu Qingxian | other | 0 |
| Jul 29, 25 | Gao Jifeng | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PASW coverage
Recent articles, reports, and earnings notes.
No research on PASW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PASW report →Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies
globenewswire.com · Nov 4
Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio
globenewswire.com · Oct 22
Ping An Biomedical Announces 1-for-40 Reverse Stock Split
globenewswire.com · Oct 21
Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years
globenewswire.com · Jul 22
All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
globenewswire.com · Mar 19
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
globenewswire.com · Jan 9
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
globenewswire.com · Jan 9
Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
globenewswire.com · Nov 28
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.